Yona Elfassi

Yona Elfassi is a Paris-based associate specializing in mergers and acquisitions, private equity and life sciences transactions.

• Engagements

  • ARCHIMED, an investment firm exclusively dedicated to the healthcare sector, in connection with the purchase of a majority stake in the Stago group, global leader in diagnostics and a specialist in hemostasis.*
  • Mauna Kea Technologies, inventor of the Cellvizio® endomicroscopy platform, on implementing its refinancing of €6.1 millions in the context of its safeguard proceedings.*
  • ARCHIMED, an investment firm exclusively dedicated to the healthcare sector, in connection with the purchase of a majority stake in the Laboratoires Rivadis group, a family-owned company specializing in hygiene, personal care, and cosmetic products for families and seniors.*
  • Crossject, a pharmaceutical company specializing in the development of drugs using its needle-free auto-injector ZENEO®, in connection with a capital increase reserved for a category of investors and the issuance of warrants for a total amount of €7.2 million.*
  • ARCHIMED, an investment firm exclusively dedicated to the healthcare sector, in connection with the purchase of a majority stake in FIM Medical, a market leader in occupational health medical devices.*
  • Arkema, a French chemical group, in connection with its acquisition, through its Irish subsidiary Bostik Industries Limited, of the Irish manufacturer Arc Building Products, which specializes in tile adhesives, floor preparation systems, building chemicals, and sealing and bonding solutions.*
  • The French biotech Abivax, in the context of its structured debt financing for a total amount of up to €150 million.*
  • Cathay Capital, a global investment firm, in connection with the sale of the Cenexi group to the Indian group Gland Pharma, controlled by the Chinese conglomerate Fosun.*

  *experience prior to joining Orrick